↓ Skip to main content

Dove Medical Press

The arsenal of pathogens and antivirulence therapeutic strategies for disarming them

Overview of attention for article published in Drug Design, Development and Therapy, May 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
94 Mendeley
Title
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them
Published in
Drug Design, Development and Therapy, May 2016
DOI 10.2147/dddt.s98939
Pubmed ID
Authors

John R Brannon, Maria Hadjifrangiskou

Abstract

Pathogens deploy an arsenal of virulence factors (VFs) to establish themselves within their infectious niche. The discovery of antimicrobial compounds and their development into therapeutics has made a monumental impact on human and microbial populations. Although humans have used antimicrobials for medicinal and agricultural purposes, microorganism populations have developed and shared resistance mechanisms to persevere in the face of classical antimicrobials. However, a positive substitute is antivirulence therapy; antivirulence therapeutics prevent or interrupt an infection by counteracting a pathogen's VFs. Their application can reduce the use of broad-spectrum antimicrobials and dampen the frequency with which resistant strains emerge. Here, we summarize the contribution of VFs to various acute and chronic infections. In correspondence with this, we provide an overview of the research and development of antivirulence strategies.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 1%
Unknown 93 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 22%
Student > Ph. D. Student 16 17%
Researcher 11 12%
Student > Master 10 11%
Student > Doctoral Student 6 6%
Other 10 11%
Unknown 20 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 20%
Agricultural and Biological Sciences 11 12%
Medicine and Dentistry 11 12%
Immunology and Microbiology 10 11%
Chemistry 8 9%
Other 14 15%
Unknown 21 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2017.
All research outputs
#15,305,492
of 25,584,565 outputs
Outputs from Drug Design, Development and Therapy
#825
of 2,271 outputs
Outputs of similar age
#158,222
of 312,292 outputs
Outputs of similar age from Drug Design, Development and Therapy
#24
of 63 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 312,292 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.